These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 27452145)

  • 21. Functions for pro-opiomelanocortin-derived peptides in obesity and diabetes.
    Mountjoy KG
    Biochem J; 2010 May; 428(3):305-24. PubMed ID: 20504281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hormone-Replacement Therapy for Melanocyte-Stimulating Hormone Deficiency.
    Reitman ML
    N Engl J Med; 2016 Jul; 375(3):278-9. PubMed ID: 27468065
    [No Abstract]   [Full Text] [Related]  

  • 23. Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin.
    Yaswen L; Diehl N; Brennan MB; Hochgeschwender U
    Nat Med; 1999 Sep; 5(9):1066-70. PubMed ID: 10470087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypothalamic pro-opiomelanocortin gene delivery ameliorates obesity and glucose intolerance in aged rats.
    Li G; Zhang Y; Wilsey JT; Scarpace PJ
    Diabetologia; 2005 Nov; 48(11):2376-85. PubMed ID: 16205885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Setmelanotide: what does it mean for clinical care of patients with obesity?
    Ryan DH
    Lancet Diabetes Endocrinol; 2020 Dec; 8(12):933-935. PubMed ID: 33137294
    [No Abstract]   [Full Text] [Related]  

  • 26. Melanocortin neurons: Multiple routes to regulation of metabolism.
    Shen WJ; Yao T; Kong X; Williams KW; Liu T
    Biochim Biophys Acta Mol Basis Dis; 2017 Oct; 1863(10 Pt A):2477-2485. PubMed ID: 28499988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lean rats with hypothalamic pro-opiomelanocortin overexpression exhibit greater diet-induced obesity and impaired central melanocortin responsiveness.
    Li G; Zhang Y; Cheng KY; Scarpace PJ
    Diabetologia; 2007 Jul; 50(7):1490-9. PubMed ID: 17505816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pro-opiomelanocortin gene is associated with serum leptin levels in lean but not in obese individuals.
    Suviolahti E; Ridderstråle M; Almgren P; Klannemark M; Melander O; Carlsson E; Carlsson M; Hedenbro J; Orho-Melander M
    Int J Obes Relat Metab Disord; 2003 Oct; 27(10):1204-11. PubMed ID: 14513068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Natural History of Obesity Due to POMC, PCSK1, and LEPR Deficiency and the Impact of Setmelanotide.
    Wabitsch M; Farooqi S; Flück CE; Bratina N; Mallya UG; Stewart M; Garrison J; van den Akker E; Kühnen P
    J Endocr Soc; 2022 Jun; 6(6):bvac057. PubMed ID: 35528826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The melanocortin system and insulin resistance in humans: insights from a patient with complete POMC deficiency and type 1 diabetes mellitus.
    Aslan IR; Ranadive SA; Valle I; Kollipara S; Noble JA; Vaisse C
    Int J Obes (Lond); 2014 Jan; 38(1):148-51. PubMed ID: 23649472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The melanocortin receptors: lessons from knockout models.
    Butler AA; Cone RD
    Neuropeptides; 2002; 36(2-3):77-84. PubMed ID: 12359499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene expression of pro-opiomelanocortin and melanocortin receptors is regulated in the hypothalamus and mesocorticolimbic system following nicotine administration.
    Tapinc DE; Ilgin R; Kaya E; Gozen O; Ugur M; Koylu EO; Kanit L; Keser A; Balkan B
    Neurosci Lett; 2017 Jan; 637():75-79. PubMed ID: 27890744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypothalamic POMC or MC4R deficiency impairs counterregulatory responses to hypoglycemia in mice.
    Tooke BP; Yu H; Adams JM; Jones GL; Sutton-Kennedy T; Mundada L; Qi NR; Low MJ; Chhabra KH
    Mol Metab; 2019 Feb; 20():194-204. PubMed ID: 30503832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A missense mutation disrupting a dibasic prohormone processing site in pro-opiomelanocortin (POMC) increases susceptibility to early-onset obesity through a novel molecular mechanism.
    Challis BG; Pritchard LE; Creemers JW; Delplanque J; Keogh JM; Luan J; Wareham NJ; Yeo GS; Bhattacharyya S; Froguel P; White A; Farooqi IS; O'Rahilly S
    Hum Mol Genet; 2002 Aug; 11(17):1997-2004. PubMed ID: 12165561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential control of metabolic and cardiovascular functions by melanocortin-4 receptors in proopiomelanocortin neurons.
    do Carmo JM; da Silva AA; Rushing JS; Pace B; Hall JE
    Am J Physiol Regul Integr Comp Physiol; 2013 Aug; 305(4):R359-68. PubMed ID: 23842677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypothalamic POMC deficiency increases circulating adiponectin despite obesity.
    Yu H; Chhabra KH; Thompson Z; Jones GL; Kiran S; Shangguan G; Low MJ
    Mol Metab; 2020 May; 35():100957. PubMed ID: 32244188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leptin and melanocortin signaling in the hypothalamus.
    Bjørbaek C; Hollenberg AN
    Vitam Horm; 2002; 65():281-311. PubMed ID: 12481551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proopiomelanocortin deficiency diagnosed in infancy in two boys and a review of the known cases.
    Graves LE; Khouri JM; Kristidis P; Verge CF
    J Paediatr Child Health; 2021 Apr; 57(4):484-490. PubMed ID: 33666293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of melanocortin signalling in the control of body weight: evidence from human and murine genetic models.
    Yeo GS; Farooqi IS; Challis BG; Jackson RS; O'Rahilly S
    QJM; 2000 Jan; 93(1):7-14. PubMed ID: 10623776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The neuronal histamine H(1) and pro-opiomelanocortin-melanocortin 4 receptors: independent regulation of food intake and energy expenditure.
    Yoshimatsu H
    Peptides; 2006 Feb; 27(2):326-32. PubMed ID: 16343692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.